Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
Global Anti-CD47 Antibody Market Growth (Status and Outlook) 2024-2030
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Anti-CD47 Antibody Market Size 2019-2030 2.1.2 Anti-CD47 Antibody Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Anti-CD47 Antibody Segment by Type 2.2.1 Monoclonal Antibody 2.2.2 Polyclonal Antibody 2.3 Anti-CD47 Antibody Market Size by Type 2.3.1 Anti-CD47 Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Anti-CD47 Antibody Market Size Market Share by Type (2019-2024) 2.4 Anti-CD47 Antibody Segment by Application 2.4.1 Biotechnology 2.4.2 Medical 2.4.3 University 2.4.4 Others 2.5 Anti-CD47 Antibody Market Size by Application 2.5.1 Anti-CD47 Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Anti-CD47 Antibody Market Size Market Share by Application (2019-2024) 3 Anti-CD47 Antibody Market Size by Player 3.1 Anti-CD47 Antibody Market Size Market Share by Players 3.1.1 Global Anti-CD47 Antibody Revenue by Players (2019-2024) 3.1.2 Global Anti-CD47 Antibody Revenue Market Share by Players (2019-2024) 3.2 Global Anti-CD47 Antibody Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Anti-CD47 Antibody by Regions 4.1 Anti-CD47 Antibody Market Size by Regions (2019-2024) 4.2 Americas Anti-CD47 Antibody Market Size Growth (2019-2024) 4.3 APAC Anti-CD47 Antibody Market Size Growth (2019-2024) 4.4 Europe Anti-CD47 Antibody Market Size Growth (2019-2024) 4.5 Middle East & Africa Anti-CD47 Antibody Market Size Growth (2019-2024) 5 Americas 5.1 Americas Anti-CD47 Antibody Market Size by Country (2019-2024) 5.2 Americas Anti-CD47 Antibody Market Size by Type (2019-2024) 5.3 Americas Anti-CD47 Antibody Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Anti-CD47 Antibody Market Size by Region (2019-2024) 6.2 APAC Anti-CD47 Antibody Market Size by Type (2019-2024) 6.3 APAC Anti-CD47 Antibody Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Anti-CD47 Antibody by Country (2019-2024) 7.2 Europe Anti-CD47 Antibody Market Size by Type (2019-2024) 7.3 Europe Anti-CD47 Antibody Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Anti-CD47 Antibody by Region (2019-2024) 8.2 Middle East & Africa Anti-CD47 Antibody Market Size by Type (2019-2024) 8.3 Middle East & Africa Anti-CD47 Antibody Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Anti-CD47 Antibody Market Forecast 10.1 Global Anti-CD47 Antibody Forecast by Regions (2025-2030) 10.1.1 Global Anti-CD47 Antibody Forecast by Regions (2025-2030) 10.1.2 Americas Anti-CD47 Antibody Forecast 10.1.3 APAC Anti-CD47 Antibody Forecast 10.1.4 Europe Anti-CD47 Antibody Forecast 10.1.5 Middle East & Africa Anti-CD47 Antibody Forecast 10.2 Americas Anti-CD47 Antibody Forecast by Country (2025-2030) 10.2.1 United States Anti-CD47 Antibody Market Forecast 10.2.2 Canada Anti-CD47 Antibody Market Forecast 10.2.3 Mexico Anti-CD47 Antibody Market Forecast 10.2.4 Brazil Anti-CD47 Antibody Market Forecast 10.3 APAC Anti-CD47 Antibody Forecast by Region (2025-2030) 10.3.1 China Anti-CD47 Antibody Market Forecast 10.3.2 Japan Anti-CD47 Antibody Market Forecast 10.3.3 Korea Anti-CD47 Antibody Market Forecast 10.3.4 Southeast Asia Anti-CD47 Antibody Market Forecast 10.3.5 India Anti-CD47 Antibody Market Forecast 10.3.6 Australia Anti-CD47 Antibody Market Forecast 10.4 Europe Anti-CD47 Antibody Forecast by Country (2025-2030) 10.4.1 Germany Anti-CD47 Antibody Market Forecast 10.4.2 France Anti-CD47 Antibody Market Forecast 10.4.3 UK Anti-CD47 Antibody Market Forecast 10.4.4 Italy Anti-CD47 Antibody Market Forecast 10.4.5 Russia Anti-CD47 Antibody Market Forecast 10.5 Middle East & Africa Anti-CD47 Antibody Forecast by Region (2025-2030) 10.5.1 Egypt Anti-CD47 Antibody Market Forecast 10.5.2 South Africa Anti-CD47 Antibody Market Forecast 10.5.3 Israel Anti-CD47 Antibody Market Forecast 10.5.4 Turkey Anti-CD47 Antibody Market Forecast 10.5.5 GCC Countries Anti-CD47 Antibody Market Forecast 10.6 Global Anti-CD47 Antibody Forecast by Type (2025-2030) 10.7 Global Anti-CD47 Antibody Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 BosterBio 11.1.1 BosterBio Company Information 11.1.2 BosterBio Anti-CD47 Antibody Product Offered 11.1.3 BosterBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 BosterBio Main Business Overview 11.1.5 BosterBio Latest Developments 11.2 Leinco Technologies 11.2.1 Leinco Technologies Company Information 11.2.2 Leinco Technologies Anti-CD47 Antibody Product Offered 11.2.3 Leinco Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Leinco Technologies Main Business Overview 11.2.5 Leinco Technologies Latest Developments 11.3 Bioss 11.3.1 Bioss Company Information 11.3.2 Bioss Anti-CD47 Antibody Product Offered 11.3.3 Bioss Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Bioss Main Business Overview 11.3.5 Bioss Latest Developments 11.4 Novus Biologicals 11.4.1 Novus Biologicals Company Information 11.4.2 Novus Biologicals Anti-CD47 Antibody Product Offered 11.4.3 Novus Biologicals Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Novus Biologicals Main Business Overview 11.4.5 Novus Biologicals Latest Developments 11.5 Thermo Fisher Scientific 11.5.1 Thermo Fisher Scientific Company Information 11.5.2 Thermo Fisher Scientific Anti-CD47 Antibody Product Offered 11.5.3 Thermo Fisher Scientific Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Thermo Fisher Scientific Main Business Overview 11.5.5 Thermo Fisher Scientific Latest Developments 11.6 Biorbyt 11.6.1 Biorbyt Company Information 11.6.2 Biorbyt Anti-CD47 Antibody Product Offered 11.6.3 Biorbyt Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Biorbyt Main Business Overview 11.6.5 Biorbyt Latest Developments 11.7 Abbexa 11.7.1 Abbexa Company Information 11.7.2 Abbexa Anti-CD47 Antibody Product Offered 11.7.3 Abbexa Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Abbexa Main Business Overview 11.7.5 Abbexa Latest Developments 11.8 Bio X Cell 11.8.1 Bio X Cell Company Information 11.8.2 Bio X Cell Anti-CD47 Antibody Product Offered 11.8.3 Bio X Cell Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Bio X Cell Main Business Overview 11.8.5 Bio X Cell Latest Developments 11.9 GeneTex 11.9.1 GeneTex Company Information 11.9.2 GeneTex Anti-CD47 Antibody Product Offered 11.9.3 GeneTex Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 GeneTex Main Business Overview 11.9.5 GeneTex Latest Developments 11.10 R&D Systems 11.10.1 R&D Systems Company Information 11.10.2 R&D Systems Anti-CD47 Antibody Product Offered 11.10.3 R&D Systems Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 R&D Systems Main Business Overview 11.10.5 R&D Systems Latest Developments 11.11 LSBio 11.11.1 LSBio Company Information 11.11.2 LSBio Anti-CD47 Antibody Product Offered 11.11.3 LSBio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 LSBio Main Business Overview 11.11.5 LSBio Latest Developments 11.12 MyBioSource 11.12.1 MyBioSource Company Information 11.12.2 MyBioSource Anti-CD47 Antibody Product Offered 11.12.3 MyBioSource Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 MyBioSource Main Business Overview 11.12.5 MyBioSource Latest Developments 11.13 ProSci 11.13.1 ProSci Company Information 11.13.2 ProSci Anti-CD47 Antibody Product Offered 11.13.3 ProSci Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.13.4 ProSci Main Business Overview 11.13.5 ProSci Latest Developments 11.14 antibodies-online 11.14.1 antibodies-online Company Information 11.14.2 antibodies-online Anti-CD47 Antibody Product Offered 11.14.3 antibodies-online Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.14.4 antibodies-online Main Business Overview 11.14.5 antibodies-online Latest Developments 11.15 ABclonal Technology 11.15.1 ABclonal Technology Company Information 11.15.2 ABclonal Technology Anti-CD47 Antibody Product Offered 11.15.3 ABclonal Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.15.4 ABclonal Technology Main Business Overview 11.15.5 ABclonal Technology Latest Developments 11.16 Abnova Corporation 11.16.1 Abnova Corporation Company Information 11.16.2 Abnova Corporation Anti-CD47 Antibody Product Offered 11.16.3 Abnova Corporation Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.16.4 Abnova Corporation Main Business Overview 11.16.5 Abnova Corporation Latest Developments 11.17 G Biosciences 11.17.1 G Biosciences Company Information 11.17.2 G Biosciences Anti-CD47 Antibody Product Offered 11.17.3 G Biosciences Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.17.4 G Biosciences Main Business Overview 11.17.5 G Biosciences Latest Developments 11.18 BioLegend 11.18.1 BioLegend Company Information 11.18.2 BioLegend Anti-CD47 Antibody Product Offered 11.18.3 BioLegend Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.18.4 BioLegend Main Business Overview 11.18.5 BioLegend Latest Developments 11.19 Bio-Rad 11.19.1 Bio-Rad Company Information 11.19.2 Bio-Rad Anti-CD47 Antibody Product Offered 11.19.3 Bio-Rad Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.19.4 Bio-Rad Main Business Overview 11.19.5 Bio-Rad Latest Developments 11.20 Huabio 11.20.1 Huabio Company Information 11.20.2 Huabio Anti-CD47 Antibody Product Offered 11.20.3 Huabio Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.20.4 Huabio Main Business Overview 11.20.5 Huabio Latest Developments 11.21 BPS Bioscience 11.21.1 BPS Bioscience Company Information 11.21.2 BPS Bioscience Anti-CD47 Antibody Product Offered 11.21.3 BPS Bioscience Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.21.4 BPS Bioscience Main Business Overview 11.21.5 BPS Bioscience Latest Developments 11.22 OriGene Technologies 11.22.1 OriGene Technologies Company Information 11.22.2 OriGene Technologies Anti-CD47 Antibody Product Offered 11.22.3 OriGene Technologies Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.22.4 OriGene Technologies Main Business Overview 11.22.5 OriGene Technologies Latest Developments 11.23 St John's Laboratory 11.23.1 St John's Laboratory Company Information 11.23.2 St John's Laboratory Anti-CD47 Antibody Product Offered 11.23.3 St John's Laboratory Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.23.4 St John's Laboratory Main Business Overview 11.23.5 St John's Laboratory Latest Developments 11.24 Absolute Antibody 11.24.1 Absolute Antibody Company Information 11.24.2 Absolute Antibody Anti-CD47 Antibody Product Offered 11.24.3 Absolute Antibody Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.24.4 Absolute Antibody Main Business Overview 11.24.5 Absolute Antibody Latest Developments 11.25 NSJ Bioreagents 11.25.1 NSJ Bioreagents Company Information 11.25.2 NSJ Bioreagents Anti-CD47 Antibody Product Offered 11.25.3 NSJ Bioreagents Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.25.4 NSJ Bioreagents Main Business Overview 11.25.5 NSJ Bioreagents Latest Developments 11.26 Cell Signaling Technology 11.26.1 Cell Signaling Technology Company Information 11.26.2 Cell Signaling Technology Anti-CD47 Antibody Product Offered 11.26.3 Cell Signaling Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.26.4 Cell Signaling Technology Main Business Overview 11.26.5 Cell Signaling Technology Latest Developments 11.27 RayBiotech 11.27.1 RayBiotech Company Information 11.27.2 RayBiotech Anti-CD47 Antibody Product Offered 11.27.3 RayBiotech Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.27.4 RayBiotech Main Business Overview 11.27.5 RayBiotech Latest Developments 11.28 Beijing Solarbio Science & Technology 11.28.1 Beijing Solarbio Science & Technology Company Information 11.28.2 Beijing Solarbio Science & Technology Anti-CD47 Antibody Product Offered 11.28.3 Beijing Solarbio Science & Technology Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.28.4 Beijing Solarbio Science & Technology Main Business Overview 11.28.5 Beijing Solarbio Science & Technology Latest Developments 11.29 Bethyl Laboratories 11.29.1 Bethyl Laboratories Company Information 11.29.2 Bethyl Laboratories Anti-CD47 Antibody Product Offered 11.29.3 Bethyl Laboratories Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.29.4 Bethyl Laboratories Main Business Overview 11.29.5 Bethyl Laboratories Latest Developments 11.30 Abeomics 11.30.1 Abeomics Company Information 11.30.2 Abeomics Anti-CD47 Antibody Product Offered 11.30.3 Abeomics Anti-CD47 Antibody Revenue, Gross Margin and Market Share (2019-2024) 11.30.4 Abeomics Main Business Overview 11.30.5 Abeomics Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Anti-CD47 Antibody Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions) Table 2. Major Players of Monoclonal Antibody Table 3. Major Players of Polyclonal Antibody Table 4. Anti-CD47 Antibody Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions) Table 5. Global Anti-CD47 Antibody Market Size by Type (2019-2024) & ($ Millions) Table 6. Global Anti-CD47 Antibody Market Size Market Share by Type (2019-2024) Table 7. Anti-CD47 Antibody Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions) Table 8. Global Anti-CD47 Antibody Market Size by Application (2019-2024) & ($ Millions) Table 9. Global Anti-CD47 Antibody Market Size Market Share by Application (2019-2024) Table 10. Global Anti-CD47 Antibody Revenue by Players (2019-2024) & ($ Millions) Table 11. Global Anti-CD47 Antibody Revenue Market Share by Player (2019-2024) Table 12. Anti-CD47 Antibody Key Players Head office and Products Offered Table 13. Anti-CD47 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Anti-CD47 Antibody Market Size by Regions 2019-2024 & ($ Millions) Table 17. Global Anti-CD47 Antibody Market Size Market Share by Regions (2019-2024) Table 18. Global Anti-CD47 Antibody Revenue by Country/Region (2019-2024) & ($ millions) Table 19. Global Anti-CD47 Antibody Revenue Market Share by Country/Region (2019-2024) Table 20. Americas Anti-CD47 Antibody Market Size by Country (2019-2024) & ($ Millions) Table 21. Americas Anti-CD47 Antibody Market Size Market Share by Country (2019-2024) Table 22. Americas Anti-CD47 Antibody Market Size by Type (2019-2024) & ($ Millions) Table 23. Americas Anti-CD47 Antibody Market Size Market Share by Type (2019-2024) Table 24. Americas Anti-CD47 Antibody Market Size by Application (2019-2024) & ($ Millions) Table 25. Americas Anti-CD47 Antibody Market Size Market Share by Application (2019-2024) Table 26. APAC Anti-CD47 Antibody Market Size by Region (2019-2024) & ($ Millions) Table 27. APAC Anti-CD47 Antibody Market Size Market Share by Region (2019-2024) Table 28. APAC Anti-CD47 Antibody Market Size by Type (2019-2024) & ($ Millions) Table 29. APAC Anti-CD47 Antibody Market Size Market Share by Type (2019-2024) Table 30. APAC Anti-CD47 Antibody Market Size by Application (2019-2024) & ($ Millions) Table 31. APAC Anti-CD47 Antibody Market Size Market Share by Application (2019-2024) Table 32. Europe Anti-CD47 Antibody Market Size by Country (2019-2024) & ($ Millions) Table 33. Europe Anti-CD47 Antibody Market Size Market Share by Country (2019-2024) Table 34. Europe Anti-CD47 Antibody Market Size by Type (2019-2024) & ($ Millions) Table 35. Europe Anti-CD47 Antibody Market Size Market Share by Type (2019-2024) Table 36. Europe Anti-CD47 Antibody Market Size by Application (2019-2024) & ($ Millions) Table 37. Europe Anti-CD47 Antibody Market Size Market Share by Application (2019-2024) Table 38. Middle East & Africa Anti-CD47 Antibody Market Size by Region (2019-2024) & ($ Millions) Table 39. Middle East & Africa Anti-CD47 Antibody Market Size Market Share by Region (2019-2024) Table 40. Middle East & Africa Anti-CD47 Antibody Market Size by Type (2019-2024) & ($ Millions) Table 41. Middle East & Africa Anti-CD47 Antibody Market Size Market Share by Type (2019-2024) Table 42. Middle East & Africa Anti-CD47 Antibody Market Size by Application (2019-2024) & ($ Millions) Table 43. Middle East & Africa Anti-CD47 Antibody Market Size Market Share by Application (2019-2024) Table 44. Key Market Drivers & Growth Opportunities of Anti-CD47 Antibody Table 45. Key Market Challenges & Risks of Anti-CD47 Antibody Table 46. Key Industry Trends of Anti-CD47 Antibody Table 47. Global Anti-CD47 Antibody Market Size Forecast by Regions (2025-2030) & ($ Millions) Table 48. Global Anti-CD47 Antibody Market Size Market Share Forecast by Regions (2025-2030) Table 49. Global Anti-CD47 Antibody Market Size Forecast by Type (2025-2030) & ($ Millions) Table 50. Global Anti-CD47 Antibody Market Size Forecast by Application (2025-2030) & ($ Millions) Table 51. BosterBio Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 52. BosterBio Anti-CD47 Antibody Product Offered Table 53. BosterBio Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 54. BosterBio Main Business Table 55. BosterBio Latest Developments Table 56. Leinco Technologies Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 57. Leinco Technologies Anti-CD47 Antibody Product Offered Table 58. Leinco Technologies Main Business Table 59. Leinco Technologies Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 60. Leinco Technologies Latest Developments Table 61. Bioss Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 62. Bioss Anti-CD47 Antibody Product Offered Table 63. Bioss Main Business Table 64. Bioss Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 65. Bioss Latest Developments Table 66. Novus Biologicals Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 67. Novus Biologicals Anti-CD47 Antibody Product Offered Table 68. Novus Biologicals Main Business Table 69. Novus Biologicals Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 70. Novus Biologicals Latest Developments Table 71. Thermo Fisher Scientific Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 72. Thermo Fisher Scientific Anti-CD47 Antibody Product Offered Table 73. Thermo Fisher Scientific Main Business Table 74. Thermo Fisher Scientific Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 75. Thermo Fisher Scientific Latest Developments Table 76. Biorbyt Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 77. Biorbyt Anti-CD47 Antibody Product Offered Table 78. Biorbyt Main Business Table 79. Biorbyt Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 80. Biorbyt Latest Developments Table 81. Abbexa Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 82. Abbexa Anti-CD47 Antibody Product Offered Table 83. Abbexa Main Business Table 84. Abbexa Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 85. Abbexa Latest Developments Table 86. Bio X Cell Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 87. Bio X Cell Anti-CD47 Antibody Product Offered Table 88. Bio X Cell Main Business Table 89. Bio X Cell Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 90. Bio X Cell Latest Developments Table 91. GeneTex Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 92. GeneTex Anti-CD47 Antibody Product Offered Table 93. GeneTex Main Business Table 94. GeneTex Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 95. GeneTex Latest Developments Table 96. R&D Systems Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 97. R&D Systems Anti-CD47 Antibody Product Offered Table 98. R&D Systems Main Business Table 99. R&D Systems Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 100. R&D Systems Latest Developments Table 101. LSBio Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 102. LSBio Anti-CD47 Antibody Product Offered Table 103. LSBio Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 104. LSBio Main Business Table 105. LSBio Latest Developments Table 106. MyBioSource Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 107. MyBioSource Anti-CD47 Antibody Product Offered Table 108. MyBioSource Main Business Table 109. MyBioSource Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 110. MyBioSource Latest Developments Table 111. ProSci Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 112. ProSci Anti-CD47 Antibody Product Offered Table 113. ProSci Main Business Table 114. ProSci Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 115. ProSci Latest Developments Table 116. antibodies-online Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 117. antibodies-online Anti-CD47 Antibody Product Offered Table 118. antibodies-online Main Business Table 119. antibodies-online Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 120. antibodies-online Latest Developments Table 121. ABclonal Technology Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 122. ABclonal Technology Anti-CD47 Antibody Product Offered Table 123. ABclonal Technology Main Business Table 124. ABclonal Technology Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 125. ABclonal Technology Latest Developments Table 126. Abnova Corporation Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 127. Abnova Corporation Anti-CD47 Antibody Product Offered Table 128. Abnova Corporation Main Business Table 129. Abnova Corporation Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 130. Abnova Corporation Latest Developments Table 131. G Biosciences Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 132. G Biosciences Anti-CD47 Antibody Product Offered Table 133. G Biosciences Main Business Table 134. G Biosciences Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 135. G Biosciences Latest Developments Table 136. BioLegend Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 137. BioLegend Anti-CD47 Antibody Product Offered Table 138. BioLegend Main Business Table 139. BioLegend Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 140. BioLegend Latest Developments Table 141. Bio-Rad Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 142. Bio-Rad Anti-CD47 Antibody Product Offered Table 143. Bio-Rad Main Business Table 144. Bio-Rad Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 145. Bio-Rad Latest Developments Table 146. Huabio Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 147. Huabio Anti-CD47 Antibody Product Offered Table 148. Huabio Main Business Table 149. Huabio Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 150. Huabio Latest Developments Table 151. BPS Bioscience Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 152. BPS Bioscience Anti-CD47 Antibody Product Offered Table 153. BPS Bioscience Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 154. BPS Bioscience Main Business Table 155. BPS Bioscience Latest Developments Table 156. OriGene Technologies Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 157. OriGene Technologies Anti-CD47 Antibody Product Offered Table 158. OriGene Technologies Main Business Table 159. OriGene Technologies Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 160. OriGene Technologies Latest Developments Table 161. St John's Laboratory Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 162. St John's Laboratory Anti-CD47 Antibody Product Offered Table 163. St John's Laboratory Main Business Table 164. St John's Laboratory Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 165. St John's Laboratory Latest Developments Table 166. Absolute Antibody Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 167. Absolute Antibody Anti-CD47 Antibody Product Offered Table 168. Absolute Antibody Main Business Table 169. Absolute Antibody Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 170. Absolute Antibody Latest Developments Table 171. NSJ Bioreagents Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 172. NSJ Bioreagents Anti-CD47 Antibody Product Offered Table 173. NSJ Bioreagents Main Business Table 174. NSJ Bioreagents Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 175. NSJ Bioreagents Latest Developments Table 176. Cell Signaling Technology Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 177. Cell Signaling Technology Anti-CD47 Antibody Product Offered Table 178. Cell Signaling Technology Main Business Table 179. Cell Signaling Technology Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 180. Cell Signaling Technology Latest Developments Table 181. RayBiotech Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 182. RayBiotech Anti-CD47 Antibody Product Offered Table 183. RayBiotech Main Business Table 184. RayBiotech Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 185. RayBiotech Latest Developments Table 186. Beijing Solarbio Science & Technology Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 187. Beijing Solarbio Science & Technology Anti-CD47 Antibody Product Offered Table 188. Beijing Solarbio Science & Technology Main Business Table 189. Beijing Solarbio Science & Technology Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 190. Beijing Solarbio Science & Technology Latest Developments Table 191. Bethyl Laboratories Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 192. Bethyl Laboratories Anti-CD47 Antibody Product Offered Table 193. Bethyl Laboratories Main Business Table 194. Bethyl Laboratories Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 195. Bethyl Laboratories Latest Developments Table 196. Abeomics Details, Company Type, Anti-CD47 Antibody Area Served and Its Competitors Table 197. Abeomics Anti-CD47 Antibody Product Offered Table 198. Abeomics Main Business Table 199. Abeomics Anti-CD47 Antibody Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 200. Abeomics Latest Developments List of Figures Figure 1. Anti-CD47 Antibody Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Anti-CD47 Antibody Market Size Growth Rate 2019-2030 ($ Millions) Figure 6. Anti-CD47 Antibody Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Anti-CD47 Antibody Sales Market Share by Country/Region (2023) Figure 8. Anti-CD47 Antibody Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Anti-CD47 Antibody Market Size Market Share by Type in 2023 Figure 10. Anti-CD47 Antibody in Biotechnology Figure 11. Global Anti-CD47 Antibody Market: Biotechnology (2019-2024) & ($ Millions) Figure 12. Anti-CD47 Antibody in Medical Figure 13. Global Anti-CD47 Antibody Market: Medical (2019-2024) & ($ Millions) Figure 14. Anti-CD47 Antibody in University Figure 15. Global Anti-CD47 Antibody Market: University (2019-2024) & ($ Millions) Figure 16. Anti-CD47 Antibody in Others Figure 17. Global Anti-CD47 Antibody Market: Others (2019-2024) & ($ Millions) Figure 18. Global Anti-CD47 Antibody Market Size Market Share by Application in 2023 Figure 19. Global Anti-CD47 Antibody Revenue Market Share by Player in 2023 Figure 20. Global Anti-CD47 Antibody Market Size Market Share by Regions (2019-2024) Figure 21. Americas Anti-CD47 Antibody Market Size 2019-2024 ($ Millions) Figure 22. APAC Anti-CD47 Antibody Market Size 2019-2024 ($ Millions) Figure 23. Europe Anti-CD47 Antibody Market Size 2019-2024 ($ Millions) Figure 24. Middle East & Africa Anti-CD47 Antibody Market Size 2019-2024 ($ Millions) Figure 25. Americas Anti-CD47 Antibody Value Market Share by Country in 2023 Figure 26. United States Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 27. Canada Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 28. Mexico Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 29. Brazil Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 30. APAC Anti-CD47 Antibody Market Size Market Share by Region in 2023 Figure 31. APAC Anti-CD47 Antibody Market Size Market Share by Type in 2023 Figure 32. APAC Anti-CD47 Antibody Market Size Market Share by Application in 2023 Figure 33. China Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 34. Japan Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 35. Korea Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 36. Southeast Asia Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 37. India Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 38. Australia Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 39. Europe Anti-CD47 Antibody Market Size Market Share by Country in 2023 Figure 40. Europe Anti-CD47 Antibody Market Size Market Share by Type (2019-2024) Figure 41. Europe Anti-CD47 Antibody Market Size Market Share by Application (2019-2024) Figure 42. Germany Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 43. France Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 44. UK Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 45. Italy Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 46. Russia Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 47. Middle East & Africa Anti-CD47 Antibody Market Size Market Share by Region (2019-2024) Figure 48. Middle East & Africa Anti-CD47 Antibody Market Size Market Share by Type (2019-2024) Figure 49. Middle East & Africa Anti-CD47 Antibody Market Size Market Share by Application (2019-2024) Figure 50. Egypt Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 51. South Africa Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 52. Israel Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 53. Turkey Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 54. GCC Country Anti-CD47 Antibody Market Size Growth 2019-2024 ($ Millions) Figure 55. Americas Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 56. APAC Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 57. Europe Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 58. Middle East & Africa Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 59. United States Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 60. Canada Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 61. Mexico Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 62. Brazil Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 63. China Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 64. Japan Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 65. Korea Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 66. Southeast Asia Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 67. India Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 68. Australia Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 69. Germany Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 70. France Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 71. UK Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 72. Italy Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 73. Russia Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 74. Spain Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 75. Egypt Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 76. South Africa Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 77. Israel Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 78. Turkey Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 79. GCC Countries Anti-CD47 Antibody Market Size 2025-2030 ($ Millions) Figure 80. Global Anti-CD47 Antibody Market Size Market Share Forecast by Type (2025-2030) Figure 81. Global Anti-CD47 Antibody Market Size Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BosterBio|||Leinco Technologies|||Bioss|||Novus Biologicals|||Thermo Fisher Scientific|||Biorbyt|||Abbexa|||Bio X Cell|||GeneTex|||R&D Systems|||LSBio|||MyBioSource|||ProSci|||antibodies-online|||ABclonal Technology|||Abnova Corporation|||G Biosciences|||BioLegend|||Bio-Rad|||Huabio|||BPS Bioscience|||OriGene Technologies|||St John's Laboratory|||Absolute Antibody|||NSJ Bioreagents|||Cell Signaling Technology|||RayBiotech|||Beijing Solarbio Science & Technology|||Bethyl Laboratories|||Abeomics